Katapult Holdings' P/S remains below industry median despite share price surge due to its lower forecast growth. Investors see limited potential for revenue improvement, requiring a change of fortune for a higher P/S ratio.
Despite Katapult Holdings' recent share price increase, its P/S ratio still trails most other firms due to a weaker revenue outlook. Investors accept this as they don't foresee any significant future revenue surprises. A turn of luck is needed for a higher P/S justification.
Gainers: •$Veru Inc(VERU.US)$+25.8% (announces that in a Pre-EUA meeting held May 10 2022 FDA has agreed that the efficacy and safety data from the completed Phase 3 clinical study in hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome are sufficient to support the submission of a request for Emergency Use Authorization) •$Desktop Metal(DM.US)$+15.8% (prices offering of $100 mln of 6.0% convertible se...
Katapult股票討論區
something very compelling about this chart
Beat Earnings Estimates *again*
近兩年營收快速增長,但是營業利潤卻由於管理費用的激增,2021年下滑43%,淨利潤下滑6%。
2022前三季度營收大幅下滑29%,管理費用卻繼續增長,營業利潤和淨利潤均進入虧損區間。
目前看不到任何吸引力。
專欄Today's pre-market stock movers: PTON, NIO, RBLX, U and more
• $Veru Inc(VERU.US)$ +25.8% (announces that in a Pre-EUA meeting held May 10 2022 FDA has agreed that the efficacy and safety data from the completed Phase 3 clinical study in hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome are sufficient to support the submission of a request for Emergency Use Authorization)
• $Desktop Metal(DM.US)$ +15.8% (prices offering of $100 mln of 6.0% convertible se...
專欄Top upgrades and downgrades on 5/11
• $Arcturus Therapeutics(ARCT.US)$ : Baird Upgrades to Neutral from Underperform - PT $18 (from $21)
• $Arrowhead Pharmaceuticals(ARWR.US)$ : Baird Upgrades to Outperform from Neutral - PT $60 (from $71)
• $Cronos Group(CRON.US)$ : CIBC Upgrades to Outperformer from Neutral
• $HF Sinclair(DINO.US)$ : Cowen Upgrades to Outperform from Market Perform - PT $52 (from $38)
• $8x8(EGHT.US)$ : B. Riley Upgrades to Buy from Neutral - PT $13.50
• $Novanta(NOVT.US)$ : William...
暫無評論